[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

April 2019 - April 2016

Decade

Year

Issue

January 2018, Vol 3, No. 1, Pages 1-90

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):1. doi:10.1001/jamacardio.2017.1919
Original Investigation

Racial Differences in Plasma Levels of N-Terminal Pro–B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study

Abstract Full Text
free access has audio
JAMA Cardiol. 2018;3(1):11-17. doi:10.1001/jamacardio.2017.4207

This cohort study examines racial differences in N-terminal pro–B-type natriuretic peptide levels and their association with all-cause mortality and cause-specific mortality in the Reasons for Geographic and Racial Differences in Stroke study.

Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):18-23. doi:10.1001/jamacardio.2017.4266

This case-control study explores whether variants in the LPA locus are associated with aortic stenosis.

Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis

Abstract Full Text
open access
JAMA Cardiol. 2018;3(1):26-33. doi:10.1001/jamacardio.2017.4293

This meta-analysis examines data sets from 5 international genome-wide association studies to determine the association between elevated lipids and the risk for abdominal aortic aneurysm.

Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults

Abstract Full Text
open access
JAMA Cardiol. 2018;3(1):34-43. doi:10.1001/jamacardio.2017.4177

This biobank study uses genetic variants of CETP to assess potential risks and benefits of lifelong lower cholesteryl ester transfer protein activity on cardiovascular diseases and other outcomes in a sample of Chinese adults.

Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):44-53. doi:10.1001/jamacardio.2017.4265

Using data from the American Heart Association Get With The Guidelines-Heart Failure program registry, this observational study conducts interrupted time series and survival analyses to determine the association between the implementation of the Hospital Readmissions Reduction Program and readmission and mortality outcomes among patients hospitalized with heart failure.

Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and Outcomes: A Multicenter Registry Study

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):54-63. doi:10.1001/jamacardio.2017.4665

This cluster analysis uses data from a large registry to define 4 subtypes of atrial fibrillation that differ widely from the disease subtypes now in standard use.

Brief Report

Usefulness of Total 12-Lead QRS Voltage as a Clue to Diagnosis of Patients With Cardiac Sarcoidosis Severe Enough to Warrant Orthotopic Heart Transplant

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):64-68. doi:10.1001/jamacardio.2017.4172

This study assesses whether total electrocardiographic 12-lead QRS voltage would aid diagnosis of cardiac sarcoidosis without biopsy in patients with severe heart failure.

Electrocardiographic Findings in National Basketball Association Athletes

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):69-74. doi:10.1001/jamacardio.2017.4572

This cohort study analyzes the electrocardiographic results of National Basketball Association athletes and assesses the accuracy of athlete-specific interpretation criteria as applied to the elite professional players of this sport.

Viewpoint

The Central and Unacknowledged Role of the US Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials

Abstract Full Text
JAMA Cardiol. 2018;3(1):5-6. doi:10.1001/jamacardio.2017.4038

This Viewpoint discusses the role of the US Food and Drug Administration’s Center for Devices and Radiologic Health in the design and execution of pivotal trials that are used to support the regulatory approval of high-risk devices.

From the Heart

Heart Failure Within the Federal Prison System

Abstract Full Text
JAMA Cardiol. 2018;3(1):10. doi:10.1001/jamacardio.2017.2857
Editorial

Natriuretic Peptide Deficiency—When There Is Too Little of a Good Thing

Abstract Full Text
has audio
JAMA Cardiol. 2018;3(1):7-9. doi:10.1001/jamacardio.2017.4208
Invited Commentary

The Role of Lipoprotein(a) in Calcific Aortic Valve Disease: Insights From a Large-Cohort Genetic Study

Abstract Full Text
JAMA Cardiol. 2018;3(1):24-25. doi:10.1001/jamacardio.2017.4267

Effects of International Electrocardiographic Interpretation Recommendations on African American Athletes

Abstract Full Text
JAMA Cardiol. 2018;3(1):75-76. doi:10.1001/jamacardio.2017.4573
Review

Payment Reform to Enhance Collaboration of Primary Care and Cardiology: A Review

Abstract Full Text
has active quiz
JAMA Cardiol. 2018;3(1):77-83. doi:10.1001/jamacardio.2017.4308

This review describes a conceptual approach to delivery and payment reforms that aims to better support primary care–cardiology comanagement of chronic cardiovascular disease.

JAMA Cardiology Clinical Challenge

75-Year-Old Woman With Multiple Systemic Emboli

Abstract Full Text
has active quiz has multimedia
JAMA Cardiol. 2018;3(1):84-85. doi:10.1001/jamacardio.2017.3262

A 75-year-old woman recently diagnosed as having stage IV lung adenocarcinoma was admitted for dyspnea and weakness. Transthoracic echocardiogram showed normal biventricular function with normal wall motion and shaggy, bulky masses on the tips of both mitral valve leaflets. What would you do next?

Comment & Response

Coronary Computed Tomography–Based Fractional Flow Reserve: A Rapidly Developing Field

Abstract Full Text
JAMA Cardiol. 2018;3(1):87. doi:10.1001/jamacardio.2017.4249

Coronary Computed Tomography–Based Fractional Flow Reserve—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(1):87-88. doi:10.1001/jamacardio.2017.4252

Simulation Models of Therapy Intensification in Lipid-Lowering Medicine: Fact or Fantasy?

Abstract Full Text
JAMA Cardiol. 2018;3(1):88-89. doi:10.1001/jamacardio.2017.4344

Simulation Models of Therapy Intensification in Lipid-Lowering Medicine—Reply

Abstract Full Text
JAMA Cardiol. 2018;3(1):89. doi:10.1001/jamacardio.2017.4353

Interpretation of the ATHENA Trial—Caveats and Future Directions

Abstract Full Text
JAMA Cardiol. 2018;3(1):89-90. doi:10.1001/jamacardio.2017.4370
Correction

Error in Author Affiliations

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):90. doi:10.1001/jamacardio.2017.5100

Errors in Abstract, Text, and Figure 1 and Addition of Open Access

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):90. doi:10.1001/jamacardio.2017.5132
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2018;3(1):3. doi:10.1001/jamacardio.2017.1920
×